These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 1283321

  • 1. Loss of heterozygosity mapping in Wilms tumor indicates the involvement of three distinct regions and a limited role for nondisjunction or mitotic recombination.
    Coppes MJ, Bonetta L, Huang A, Hoban P, Chilton-MacNeill S, Campbell CE, Weksberg R, Yeger H, Reeve AE, Williams BR.
    Genes Chromosomes Cancer; 1992 Nov; 5(4):326-34. PubMed ID: 1283321
    [Abstract] [Full Text] [Related]

  • 2. Deletion of WT1 and WIT1 genes and loss of heterozygosity on chromosome 11p in Wilms tumors in Japan.
    Kaneko Y, Takeda O, Homma C, Maseki N, Miyoshi H, Tsunematsu Y, Williams BG, Saunders GF, Sakurai M.
    Jpn J Cancer Res; 1993 Jun; 84(6):616-24. PubMed ID: 8393432
    [Abstract] [Full Text] [Related]

  • 3. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.
    Charles AK, Brown KW, Berry PJ.
    Am J Pathol; 1998 Sep; 153(3):991-1000. PubMed ID: 9736048
    [Abstract] [Full Text] [Related]

  • 4. Clinicopathologic correlates of loss of heterozygosity in Wilm's tumor: a preliminary analysis.
    Grundy P, Telzerow P, Moksness J, Breslow NE.
    Med Pediatr Oncol; 1996 Nov; 27(5):429-33. PubMed ID: 8926924
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Allelic loss on chromosome 11p is a less frequent event in bilateral than in unilateral Wilms' tumours.
    Little MH, Clarke J, Byrne J, Dunn R, Smith PJ.
    Eur J Cancer; 1992 Nov; 28A(11):1876-80. PubMed ID: 1356388
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Wilms tumor genes.
    Huff V, Saunders GF.
    Biochim Biophys Acta; 1993 Dec 23; 1155(3):295-306. PubMed ID: 8268188
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Genome-wide loss of heterozygosity analysis of WT1-wild-type and WT1-mutant Wilms tumors.
    Ruteshouser EC, Hendrickson BW, Colella S, Krahe R, Pinto L, Huff V.
    Genes Chromosomes Cancer; 2005 Jun 23; 43(2):172-80. PubMed ID: 15761866
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clonality and loss of heterozygosity of WT genes are early events in the pathogenesis of nephroblastomas.
    Guertl B, Ratschek M, Harms D, Jaenig U, Leuschner I, Poremba C, Hoefler G.
    Hum Pathol; 2003 Mar 23; 34(3):278-81. PubMed ID: 12673563
    [Abstract] [Full Text] [Related]

  • 20. Nonlinkage of 16q markers to familial predisposition to Wilms' tumor.
    Huff V, Reeve AE, Leppert M, Strong LC, Douglass EC, Geiser CF, Li FP, Meadows A, Callen DF, Lenoir G.
    Cancer Res; 1992 Nov 01; 52(21):6117-20. PubMed ID: 1356625
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.